3 Best Performing ASX shares in week 47, 1 December 2021

Marc Kennis Marc Kennis, December 8, 2021

Best performing ASX shares: This week saw 3 stocks perform exceptionally well: Tuas (ASX:TUA) was up 45.8%, IDT Australia (ASX:IDT) went up 33.3% while Aston Minerals (ASX:ASO) rose 26.1%, making up the Top 3 Best performing ASX shares.

 

1. Tuas (ASX: TUA)

Industry: Technology

Tuas Limited (ASX: TUA) and its controlled entities consist of Tuas Limited and its wholly owned subsidiaries TPG Telecom Pte Limited (TPG Singapore) and Tuas Solutions Sdn Bhd. Tuas was incorporated in Australia in March 2020 in anticipation of the demerger of the Singapore operations of TPG Telecom Limited resulting from the merger between TPG Telecom Australia and Vodafone Hutchsion Australia.

Market Cap: $923M

12 month high / low: $2.32 – $0.58

 

TUAS

 

 

2. IDT Australia (ASX: IDT)

Industry: Healthcare

IDT Australia Limited (ASX: IDT) is into supply of products and provision of research and development and other technical services for the pharmaceutical and related industries.

Market Cap: $124M

12 month high / low: $0.76 – $0.17

 

IDT Australia

 

 

3. Aston Minerals (ASX: ASO)

Industry: Basic Materials

Aston Minerals Limited (ASO, formerly European Cobalt Limited) is a mineral exploration company focusing on acquiring base metals, gold and coal projects. Currently, ASO focuses on the Dobsina Project, Jouhineva Project and Edleston Gold Project.

Market Cap: $115M

12 month high / low: $0.23 – $0.03

 

Aston Minerals

 

 

Learn more about ASX-listed stocks with
Stocks Down Under!

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY26

Recent Posts

Prescient Therapeutics

Prescient Therapeutics (ASX:PTX): Its taken the plunge into a Phase 2 trial against T-Cell Lymphoma

There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…

Botanix Pharmaceuticals

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this…

beat the market

How can an investor beat the market? Here’s how to go about it

You may’ve heard the expression to ‘beat the market’. What does this mean? Well, it depends on the context in…